Amy Ladd Sells 72 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) Director Amy Ladd sold 72 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the sale, the director owned 179 shares in the company, valued at $70,364.90. The trade was a 28.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Up 0.0%

NASDAQ ISRG opened at $401.27 on Thursday. The firm has a market cap of $141.76 billion, a price-to-earnings ratio of 45.96, a price-to-earnings-growth ratio of 2.90 and a beta of 1.46. The business has a 50-day moving average price of $392.35 and a 200-day moving average price of $442.47. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.

Get Intuitive Surgical alerts:

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. Intuitive Surgical’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the company posted $1.81 earnings per share. Research analysts expect that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently added to or reduced their stakes in the stock. Main Street Group LTD purchased a new position in Intuitive Surgical in the first quarter worth $30,000. Compass Financial Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $30,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $31,000. Vermillion Wealth Management Inc. grew its stake in Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 25 shares during the last quarter. Finally, Turning Point Benefit Group Inc. grew its stake in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a report on Thursday, July 30th. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Bank of America reduced their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Citigroup dropped their price target on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research note on Friday, July 17th. Finally, The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a report on Wednesday, May 27th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $508.68.

View Our Latest Stock Analysis on ISRG

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Oppenheimer upgraded ISRG to Outperform and set a $500 price target, citing the company’s ability to “crowd out” competitors. The firm believes Medtronic’s Hugo and Intuitive’s Ottava systems pose limited near-term threats to the da Vinci franchise because of workflow, operating-room real-estate and adoption challenges. Oppenheimer upgrade report
• Positive Sentiment: Bernstein reiterated its Buy rating and maintained a $685 price target, pointing to progress on Intuitive’s next-generation gastrointestinal platform. Longer term, continued da Vinci 5 adoption, recurring instruments and service revenue, and expansion into additional procedures support the company’s growth outlook. Bernstein rating report
• Positive Sentiment: The ENCOMPASS post-market study is highlighting Intuitive’s opportunity in robotic-assisted lung biopsy. Progress in this clinical program could broaden use of the Ion platform and create additional recurring procedure-related revenue. ENCOMPASS trial report
• Neutral Sentiment: Intuitive’s second-quarter results were strong, with revenue up 18.4% to $2.89 billion and EPS of $2.80 versus the $2.48 consensus estimate. However, investors are focusing more on forward procedure growth than on the earnings beat.
• Negative Sentiment: U.S. procedure growth slowed in the second quarter. Analysts attributed some of the weakness to Affordable Care Act-related care deferrals, which could be temporary, but the issue raises near-term uncertainty around demand and revenue growth. U.S. procedure growth report
• Negative Sentiment: Insiders reported several sales, including Director Gary Guthart’s 10,000-share sale for approximately $4 million and smaller sales by Director Amy Ladd and EVP Gary Loeb. The trades were conducted under pre-arranged Rule 10b5-1 plans, reducing their value as a discretionary bearish signal, but they may weigh modestly on sentiment.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Featured Stories

• Five stocks we like better than Intuitive Surgical
• GE Vernova’s AI Power Boom Faces a Profit Test
• Cardinal Health Earnings: Can Perfection Get Priced In Twice?
• Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
• Legacy Jet Builders Stall While Embraer Accelerates to New Highs

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.